{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:50:40Z","timestamp":1753890640345,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Autoimmune encephalitis (AE) is a group of disorders characterized by antibodies targeting neuronal cell surface, intracellular structures and synapse antigens. Treatment for AE involves reducing antibody levels and suppressing immune-mediated inflammation using intravenous immunoglobulin, plasma exchange (PE), and immune-modulating agents. PE is commonly used in autoimmune neurological diseases, but the safety issues of PE are worth continuous attention. This case report describes a 28-year-old patient who was diagnosed with anti-GAD65 AE and underwent treatments including double filtration plasmapheresis (DFPP), steroids, and immunosuppressive agents. However, complications arose when the patient developed thrombosis and was diagnosed with type II heparin-induced thrombocytopenia (HIT). He was treated with an oral anticoagulant and eventually recovered. One month later, follow-up examinations showed no presence of emboli and his epilepsy remained well controlled. There is a risk of HIT, a potentially dangerous adverse reaction to heparin during treatment of PE. The current case highlights the importance of monitoring for HIT during PE and the need for alternative anticoagulants.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1574698","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T05:11:35Z","timestamp":1744261895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Heparin-induced thrombocytopenia following double filtration plasmapheresis in a patient with anti-GAD65 autoimmune encephalitis"],"prefix":"10.3389","volume":"12","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanwan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufang","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/diagnostics13152589","article-title":"Autoimmune encephalitis with antibodies: anti-NMDAR, anti-AMPAR, anti-GQ1b, anti-DPPX, anti-CASPR2, anti-LGI1, anti-RI, anti-yo, anti-hu, anti-CV2 and anti-GABAAR, in the course of psychoses, neoplastic diseases, and paraneoplastic syndromes","volume":"13","author":"Braczkowski","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1756285617722347","DOI":"10.1177\/1756285617722347","article-title":"Treatment strategies for autoimmune encephalitis","volume":"11","author":"Shin","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s11481-021-10004-9","article-title":"The role of plasma exchange in the treatment of refractory autoimmune neurological diseases: a narrative review","volume":"16","author":"Jacob","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jca.21953","article-title":"Immunoadsorption and plasma exchange-efficient treatment options for neurological autoimmune diseases","volume":"37","author":"Boedecker","year":"2022","journal-title":"J Clin Apher"},{"key":"B7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the writing committee of the American society for apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"key":"B8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/jca.21544","article-title":"Membrane therapeutic plasma exchange with and without heparin anticoagulation","volume":"32","author":"Brunetta Gavrani\u0107","year":"2017","journal-title":"J Clin Apher"},{"key":"B9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/aln.0000000000004090","article-title":"Heparin-induced thrombocytopenia: perioperative diagnosis and management","volume":"136","author":"Koster","year":"2022","journal-title":"Anesthesiology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/17474086.2021.1905512","article-title":"Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment","volume":"14","author":"Hvas","year":"2021","journal-title":"Expert Rev Hematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/jth.14359","article-title":"A computerized scoring system to improve assessment of heparin-induced thrombocytopenia risk","volume":"17","author":"Gallo","year":"2019","journal-title":"J Thromb Haemost"},{"key":"B12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1177\/1076029615578167","article-title":"Heparin reexposure in patients with a history of heparin-induced thrombocytopenia","volume":"21","author":"Dhakal","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2724304","DOI":"10.1155\/2019\/2724304","article-title":"A case of heparin-induced thrombocytopenia that developed in the therapeutic course of anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"2019","author":"Nonaka","year":"2019","journal-title":"Case Rep Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.amjsurg.2019.07.039","article-title":"Improved prediction of HIT in the SICU using an improved model of the Warkentin 4-T system: 3-T","volume":"219","author":"Bloom","year":"2020","journal-title":"Am J Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.21542\/gcsp.2018.15","article-title":"Heparin-induced thrombocytopenia (HIT): identification and treatment pathways","volume":"2018","author":"Fathi","year":"2018","journal-title":"Glob Cardiol Sci Pract"},{"key":"B16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11239-019-02011-8","article-title":"Pharmacist involvement in clinical assessment and laboratory testing for heparin-induced thrombocytopenia","volume":"50","author":"Condon","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.trsl.2020.04.014","article-title":"Pathogenesis of heparin-induced thrombocytopenia","volume":"225","author":"Arepally","year":"2020","journal-title":"Transl Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s11096-021-01260-z","article-title":"Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis","volume":"43","author":"Colarossi","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"B19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jcpt.13537","article-title":"Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia","volume":"47","author":"Cirbus","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/1744-9987.13937","article-title":"A comparison of methods of plasmapheresis for the treatment of late antibody mediated rejection in kidney transplant recipients","volume":"27","author":"Caliskan","year":"2023","journal-title":"Ther Apher Dial"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1182\/blood-2022-165972","article-title":"Double filtration plasmapheresis for desensitization during haploidentical stem cell transplantation in patients with positive donor-specific anti-HLA antibodies","volume":"140","author":"Liu","year":"2022","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1358863X19898253","article-title":"Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management","volume":"25","author":"Hogan","year":"2020","journal-title":"Vasc Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1111\/ijlh.12316","article-title":"Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease","volume":"37","author":"Arachchillage","year":"2015","journal-title":"Int J Lab Hematol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/jca.20073","article-title":"Heparin-induced thrombocytopenia type II: a rare but significant complication of plasma exchange","volume":"21","author":"Laird","year":"2006","journal-title":"J Clin Apher"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.amjmed.2014.08.004","article-title":"Heparin-induced thrombocytopenia in patients receiving plasma exchange","volume":"127","author":"Limaye","year":"2014","journal-title":"Am J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1053\/j.ajkd.2022.10.017","article-title":"Therapeutic plasma exchange: core curriculum 2023","volume":"81","author":"Cervantes","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American society of hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"B28","doi-asserted-by":"publisher","first-page":"103174","DOI":"10.1016\/j.transci.2021.103174","article-title":"Therapeutic plasma exchange (TPE) as a plausible rescue therapy in severe vaccine-induced immune thrombotic thrombocytopenia","volume":"60","author":"Rock","year":"2021","journal-title":"Transfus Apher Sci"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1574698\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T05:11:36Z","timestamp":1744261896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1574698\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":28,"alternative-id":["10.3389\/fcvm.2025.1574698"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1574698","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"article-number":"1574698"}}